US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
BRPI0207767B8
(pt)
*
|
2001-02-24 |
2021-05-25 |
Boehringer Ingelheim Pharma |
derivados de xantina, seu uso, composições farmacêuticas, seus processos de preparação, e sais fisiologicamente aceitáveis
|
EP1385508B1
(en)
|
2001-03-27 |
2008-05-21 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
CA2460512A1
(en)
|
2001-09-14 |
2003-03-27 |
Mitsubishi Pharma Corporation |
Thiazolidine derivatives and medicinal use thereof
|
DE60304911D1
(de)
|
2002-02-25 |
2006-06-08 |
Eisai Co Ltd |
Xanthin-Derivate als DPP-IV-Inhibitoren
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
CN1678586A
(zh)
|
2002-06-27 |
2005-10-05 |
舍林股份公司 |
取代的喹啉ccr5受体拮抗剂
|
TW200404796A
(en)
*
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
US7569574B2
(en)
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
AU2003301436A1
(en)
|
2002-10-17 |
2004-05-04 |
Amgen Inc. |
Benzimidazole derivatives and their use as vanilloid receptor ligands
|
US7482337B2
(en)
*
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10254304A1
(de)
*
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
JP2005170792A
(ja)
*
|
2002-11-22 |
2005-06-30 |
Mitsubishi Pharma Corp |
L−プロリン誘導体およびその医薬としての用途。
|
US7109192B2
(en)
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
UY28103A1
(es)
*
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
WO2004069828A1
(ja)
*
|
2003-02-04 |
2004-08-19 |
Mitsubishi Pharma Corporation |
ピペリジン化合物およびその医薬用途
|
CL2004000409A1
(es)
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
US7713983B2
(en)
|
2003-03-03 |
2010-05-11 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
CN1894234A
(zh)
|
2003-03-25 |
2007-01-10 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
EP2364982A1
(en)
*
|
2003-04-18 |
2011-09-14 |
ONO Pharmaceutical Co., Ltd. |
Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof
|
NZ572274A
(en)
|
2003-05-05 |
2009-06-26 |
Probiodrug Ag |
Use of effectors of glutaminyl and glutamate cyclases
|
ATE464889T1
(de)
|
2003-05-05 |
2010-05-15 |
Probiodrug Ag |
Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
|
ATE447574T1
(de)
*
|
2003-05-14 |
2009-11-15 |
Merck & Co Inc |
3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
|
AU2003902946A0
(en)
*
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
PT1638970E
(pt)
*
|
2003-06-20 |
2010-12-13 |
Hoffmann La Roche |
Derivados de pirid(2,1-a)isoquinolina como inibidores de dpp-iv
|
WO2005030121A2
(en)
*
|
2003-06-30 |
2005-04-07 |
Hif Bio, Inc. |
Compounds, compositions and methods
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7678909B1
(en)
|
2003-08-13 |
2010-03-16 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
KR20060041309A
(ko)
*
|
2003-08-13 |
2006-05-11 |
다케다 야쿠힌 고교 가부시키가이샤 |
4-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
JP2007505121A
(ja)
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
EA010108B1
(ru)
|
2003-10-15 |
2008-06-30 |
Пробиодруг Аг |
Применение эффекторов глутаминил- и глутаматциклаз
|
EP1680120A2
(en)
|
2003-11-03 |
2006-07-19 |
Probiodrug AG |
Combinations useful for the treatment of neuronal disorders
|
KR20060109911A
(ko)
|
2003-11-17 |
2006-10-23 |
노파르티스 아게 |
디펩티딜 펩티다제 ⅳ 억제제의 용도
|
DE10355304A1
(de)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
JP4958560B2
(ja)
*
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Gpcr受容体作動薬としてのヘテロ環誘導体
|
ES2332920T3
(es)
|
2004-01-20 |
2010-02-15 |
Novartis Ag |
Proceso y formulacion de compresion directa.
|
WO2005073186A1
(ja)
*
|
2004-01-29 |
2005-08-11 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
CN101684089A
(zh)
*
|
2004-02-05 |
2010-03-31 |
杏林制药株式会社 |
双环酯类衍生物
|
US7304086B2
(en)
|
2004-02-05 |
2007-12-04 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
US7560569B2
(en)
*
|
2004-02-18 |
2009-07-14 |
Kyorin Pharmaceutical Co., Ltd |
Bicycloamide derivative
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
DE102004009039A1
(de)
*
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
US7514571B2
(en)
*
|
2004-02-27 |
2009-04-07 |
Kyorin Pharmaceutical Co., Ltd. |
Bicyclo derivative
|
US7348346B2
(en)
|
2004-03-08 |
2008-03-25 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
US7732446B1
(en)
|
2004-03-11 |
2010-06-08 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
AU2004318013B8
(en)
|
2004-03-15 |
2011-10-06 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7179809B2
(en)
*
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
US7439370B2
(en)
*
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
SI1753748T1
(sl)
|
2004-05-12 |
2009-12-31 |
Pfizer Prod Inc |
Derivati prolina in njihova uporaba kot inhibitorji dipeptidil-peptidaze IV
|
CN1968949B
(zh)
*
|
2004-05-12 |
2011-05-04 |
辉瑞产品公司 |
脯氨酸衍生物和其作为二肽基肽酶iv抑制剂的用途
|
FR2870538B1
(fr)
*
|
2004-05-19 |
2006-07-14 |
Servier Lab |
Nouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
WO2005118555A1
(en)
*
|
2004-06-04 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
WO2006008644A1
(en)
*
|
2004-07-13 |
2006-01-26 |
Pfizer Products Inc. |
Antidiabetic compounds
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
ATE553077T1
(de)
*
|
2004-07-23 |
2012-04-15 |
Nuada Llc |
Peptidaseinhibitoren
|
JP5135795B2
(ja)
|
2004-08-27 |
2013-02-06 |
小野薬品工業株式会社 |
塩基性基を含有する化合物およびその用途
|
US7928107B2
(en)
|
2004-09-02 |
2011-04-19 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
DE102004043944A1
(de)
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
FR2876688B1
(fr)
*
|
2004-10-14 |
2007-03-16 |
Aventis Pharma Sa |
Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
EP1828192B1
(en)
|
2004-12-21 |
2014-12-03 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2006073167A1
(ja)
*
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
DOP2006000008A
(es)
*
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
WO2006088129A1
(ja)
*
|
2005-02-18 |
2006-08-24 |
Mitsubishi Pharma Corporation |
プロリン誘導体の塩、またはその溶媒和物、及びその製造方法
|
BRPI0608074A2
(pt)
*
|
2005-03-03 |
2009-11-03 |
Janssen Pharmaceutica Nv |
derivados de oxa-diaza-espiro-[5.5]-undecanona substituìdos e uso como antagonistas da neurocinina do mesmo
|
CN101137657B
(zh)
|
2005-03-08 |
2011-02-02 |
詹森药业有限公司 |
作为神经激肽(nk1)拮抗剂的二氮杂-螺-[4.4]-壬烷衍生物
|
EP2527337A1
(en)
*
|
2005-04-14 |
2012-11-28 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
BRPI0608469A2
(pt)
|
2005-04-22 |
2010-01-05 |
Alantos Pharmaceuticals Holding Inc |
inibidores de dipeptidil peptidase-iv
|
JP5100375B2
(ja)
*
|
2005-04-26 |
2012-12-19 |
田辺三菱製薬株式会社 |
糖・脂質代謝異常の予防及び/又は治療薬
|
US8754032B2
(en)
*
|
2005-06-03 |
2014-06-17 |
Mitsubishi Tanabe Pharma Corporation |
Concomitant pharmaceutical agents and use thereof
|
EP2356997A1
(en)
|
2005-06-06 |
2011-08-17 |
Georgetown University |
Compositions and methods for lipo modeling
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
TW200738701A
(en)
|
2005-07-26 |
2007-10-16 |
Du Pont |
Fungicidal carboxamides
|
DE102005035891A1
(de)
*
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
US8143285B2
(en)
|
2005-09-06 |
2012-03-27 |
Shionogi & Co., Ltd. |
Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
|
CA2622472C
(en)
|
2005-09-14 |
2013-11-19 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors for treating diabetes
|
US8222411B2
(en)
|
2005-09-16 |
2012-07-17 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
EP1961744B1
(en)
|
2005-11-18 |
2013-04-17 |
Ono Pharmaceutical Co., Ltd. |
Basic group-containing compound and use thereof
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
CA2645154C
(en)
*
|
2006-03-08 |
2011-11-29 |
Kyorin Pharmaceutical Co., Ltd. |
Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2007110364A1
(en)
*
|
2006-03-28 |
2007-10-04 |
High Point Pharmaceuticals, Llc |
Benzothiazoles having histamine h3 receptor activity
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
RS51745B
(en)
|
2006-04-11 |
2011-10-31 |
Arena Pharmaceuticals Inc. |
PROCEDURE FOR USING GPR119 RECEPTORS FOR INDENTIFICATION OF UNITS USEFUL FOR BONE WEIGHT INCREASE
|
TW200815351A
(en)
*
|
2006-05-02 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds
|
BRPI0711558A2
(pt)
|
2006-05-04 |
2011-11-08 |
Boeringer Ingelheim Internat Gmbh |
polimorfos
|
EP1852108A1
(en)
*
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
WO2007132846A1
(ja)
|
2006-05-16 |
2007-11-22 |
Ono Pharmaceutical Co., Ltd. |
保護されていてもよい酸性基を含有する化合物およびその用途
|
EA016054B1
(ru)
*
|
2006-06-16 |
2012-01-30 |
Х. Лундбекк А/С |
Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил] пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли
|
WO2008017670A1
(en)
|
2006-08-08 |
2008-02-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TW200838536A
(en)
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
EP2123636B1
(en)
*
|
2007-03-22 |
2012-03-21 |
Kyorin Pharmaceutical Co., Ltd. |
Method for producing aminoacetylpyrrolidinecarbonitrile derivative
|
EP2143443B1
(en)
|
2007-04-03 |
2014-11-19 |
Mitsubishi Tanabe Pharma Corporation |
A combination of dipeptidyl peptidase iv inhibitor and sweetener for use in the treatment of obesity
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
WO2009143153A1
(en)
*
|
2008-05-23 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Substituted pyrrolidine amides as modulators of the histamine h3 receptor
|
KR20190016601A
(ko)
|
2008-08-06 |
2019-02-18 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
JP5476305B2
(ja)
*
|
2008-08-07 |
2014-04-23 |
杏林製薬株式会社 |
ビシクロ[2.2.2]オクチルアミン誘導体の製造方法
|
US20110152342A1
(en)
*
|
2008-08-14 |
2011-06-23 |
Hiroshi Uchida |
Stabilized pharmaceutical composition
|
EP2326326B1
(en)
|
2008-08-15 |
2019-10-09 |
Boehringer Ingelheim International GmbH |
Dpp-4 inhibitors for use for the treatment of wound healing in diabetic patients
|
RU2011113823A
(ru)
|
2008-09-10 |
2012-10-20 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
MX2011004258A
(es)
|
2008-10-22 |
2011-06-01 |
Merck Sharp & Dohme |
Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
|
EP2362731B1
(en)
|
2008-10-31 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
KR20110103968A
(ko)
|
2008-12-23 |
2011-09-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
유기 화합물의 염 형태
|
TW201036975A
(en)
|
2009-01-07 |
2010-10-16 |
Boehringer Ingelheim Int |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
|
TWI466672B
(zh)
|
2009-01-29 |
2015-01-01 |
Boehringer Ingelheim Int |
小兒科病人糖尿病之治療
|
US20120094894A1
(en)
|
2009-02-13 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
|
EP2412370A4
(en)
|
2009-03-27 |
2013-05-22 |
Kyorin Seiyaku Kk |
MATRIX-LIKE EXTENDED RELEASE PREPARATION CONTAINING A BASIC ADDITIVE
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
MX364651B
(es)
|
2009-11-27 |
2019-05-03 |
Boehringer Ingelheim Int Gmbh Star |
Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
|
ES2596324T3
(es)
|
2009-12-18 |
2017-01-05 |
Mitsubishi Tanabe Pharma Corporation |
Preparación de teneligliptina con elución estabilizada
|
CA2786314A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
WO2011113947A1
(en)
|
2010-03-18 |
2011-09-22 |
Boehringer Ingelheim International Gmbh |
Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
|
WO2011127051A1
(en)
|
2010-04-06 |
2011-10-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
GB201006166D0
(en)
*
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
EP2566469B1
(en)
|
2010-05-05 |
2022-12-21 |
Boehringer Ingelheim International GmbH |
Combination therapy
|
EP2585101A1
(en)
|
2010-06-24 |
2013-05-01 |
Boehringer Ingelheim International GmbH |
Diabetes therapy
|
US10894787B2
(en)
|
2010-09-22 |
2021-01-19 |
Arena Pharmaceuticals, Inc. |
Modulators of the GPR119 receptor and the treatment of disorders related thereto
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
CN103619334A
(zh)
*
|
2011-01-19 |
2014-03-05 |
朱红文 |
噻唑烷衍生物和其治疗用途
|
BR122021002201A8
(pt)
|
2011-02-25 |
2023-04-11 |
Merck Sharp & Dohme |
Composto, composição, uso de um composto, e, método de tratamento de um distúrbio, condição ou doença
|
WO2012135570A1
(en)
|
2011-04-01 |
2012-10-04 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012145361A1
(en)
|
2011-04-19 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US20140051714A1
(en)
|
2011-04-22 |
2014-02-20 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145603A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
JP5863789B2
(ja)
*
|
2011-06-01 |
2016-02-17 |
田辺三菱製薬株式会社 |
ピラゾール誘導体の製造方法
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
MX366629B
(es)
|
2011-07-15 |
2019-07-17 |
Boehringer Ingelheim Int |
Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP3685839A1
(en)
|
2012-05-14 |
2020-07-29 |
Boehringer Ingelheim International GmbH |
Linagliptin for use in the treatment of albuminuria and kidney related diseases
|
CN103420981A
(zh)
*
|
2012-05-21 |
2013-12-04 |
中国医学科学院药物研究所 |
含有取代吡咯烷基的硫代吗啉类化合物
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
KR20150036245A
(ko)
|
2012-08-02 |
2015-04-07 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병 트리시클릭 화합물
|
WO2014041560A2
(en)
*
|
2012-08-31 |
2014-03-20 |
Glenmark Pharmaceuticals Limited; Glenmark Generics Limited |
Process for the preparation of teneligliptin
|
WO2014074668A1
(en)
|
2012-11-08 |
2014-05-15 |
Arena Pharmaceuticals, Inc. |
Modulators of gpr119 and the treatment of disorders related thereto
|
MX2015010935A
(es)
|
2013-02-22 |
2015-10-29 |
Merck Sharp & Dohme |
Compuestos biciclicos antidiabeticos.
|
US9650375B2
(en)
|
2013-03-14 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as anti-diabetic agents
|
HUE035844T2
(en)
|
2013-03-15 |
2018-05-28 |
Monsanto Technology Llc |
N, C-disubstituted azoles for nematode pest control
|
CN104177295B
(zh)
*
|
2013-05-24 |
2016-08-17 |
南京华威医药科技开发有限公司 |
替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法
|
CN104211685A
(zh)
*
|
2013-05-29 |
2014-12-17 |
中国医学科学院药物研究所 |
含有取代吡咯烷基的硫代吗啉类化合物
|
CN103275010A
(zh)
*
|
2013-05-30 |
2013-09-04 |
上海皓元生物医药科技有限公司 |
一种1-(3-甲基-1-苯基-1h-吡唑-5-基)哌嗪的制备方法
|
CN104230917B
(zh)
*
|
2013-06-24 |
2017-04-05 |
南京华威医药科技开发有限公司 |
一种脯氨酸衍生物盐的水合物及其生产方法
|
WO2015019238A1
(en)
|
2013-08-06 |
2015-02-12 |
Ranbaxy Laboratories Limited |
Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one
|
WO2015019239A1
(en)
|
2013-08-06 |
2015-02-12 |
Ranbaxy Laboratories Limited |
Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
WO2015063709A1
(en)
|
2013-10-31 |
2015-05-07 |
Ranbaxy Laboratories Limited |
Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
|
EP3110449B1
(en)
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|
CN105085358A
(zh)
*
|
2014-05-07 |
2015-11-25 |
中国医学科学院药物研究所 |
4-取代吡咯烷甲酰基硫代吗啉类dpp-iv抑制剂
|
CN105085359A
(zh)
*
|
2014-05-07 |
2015-11-25 |
中国医学科学院药物研究所 |
含氮杂环取代的吡咯烷甲酰基硫代吗啉类dpp-iv抑制剂
|
WO2015173779A1
(en)
|
2014-05-16 |
2015-11-19 |
Micro Labs Limited |
Process for the preparation of teneligliptin and its novel intermediates
|
CN105294673B
(zh)
*
|
2014-06-18 |
2018-04-13 |
四川科伦药物研究院有限公司 |
一种氢溴酸替格列汀的合成方法
|
CN104529856A
(zh)
*
|
2015-01-13 |
2015-04-22 |
佛山市赛维斯医药科技有限公司 |
一种硝基金刚烷酰胺衍生物、其制备方法和用途
|
CN104496876A
(zh)
*
|
2015-01-13 |
2015-04-08 |
佛山市赛维斯医药科技有限公司 |
一种羟基金刚烷酰胺衍生物、其制备方法和用途
|
CN104529858A
(zh)
*
|
2015-01-13 |
2015-04-22 |
佛山市赛维斯医药科技有限公司 |
含卤代金刚烷和酰胺类衍生物、其制备方法和用途
|
KR20220070057A
(ko)
|
2015-03-09 |
2022-05-27 |
인테크린 테라퓨틱스, 아이엔씨. |
비알코올성 지방간 질환 및/또는 지방이영양증의 치료 방법
|
KR20180094940A
(ko)
*
|
2015-12-02 |
2018-08-24 |
아스트레아 테라퓨틱스 엘엘씨 |
피페리디닐 노시셉틴 수용체 화합물
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
WO2017211979A1
(en)
|
2016-06-10 |
2017-12-14 |
Boehringer Ingelheim International Gmbh |
Combinations of linagliptin and metformin
|
EP3551176A4
(en)
|
2016-12-06 |
2020-06-24 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC HETEROCYCLIC COMPOUNDS
|
US10968232B2
(en)
|
2016-12-20 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
WO2018162722A1
(en)
|
2017-03-09 |
2018-09-13 |
Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke |
Dpp-4 inhibitors for use in treating bone fractures
|
AU2018249822A1
(en)
|
2017-04-03 |
2019-10-31 |
Coherus Biosciences Inc. |
PPArgamma agonist for treatment of progressive supranuclear palsy
|
WO2019079578A1
(en)
*
|
2017-10-19 |
2019-04-25 |
Amgen Inc. |
BENZIMIDAZOLE DERIVATIVES AND USES THEREOF
|
JP6985179B2
(ja)
*
|
2018-02-27 |
2021-12-22 |
田辺三菱製薬株式会社 |
プロリンアミド化合物の製造方法
|
CN108997308A
(zh)
*
|
2018-07-09 |
2018-12-14 |
西藏大学 |
一种苯并咪唑类衍生物及其制备方法和应用
|
KR102494848B1
(ko)
|
2018-10-10 |
2023-02-02 |
주식회사 파마코스텍 |
테네리글립틴 2토실산염 2수화물의 결정형 ⅰ형 및 그 제조방법
|
KR20200127480A
(ko)
|
2019-05-02 |
2020-11-11 |
연성정밀화학(주) |
테네리글립틴 에디실산염 결정형 및 이의 제조방법
|
JP2023554405A
(ja)
|
2020-12-17 |
2023-12-27 |
アストラゼネカ・アクチエボラーグ |
N-(2-(4-シアノチアゾリジン-3-イル)-2-オキソエチル)-キノリン-4-カルボキサミド
|
KR20240057402A
(ko)
*
|
2021-07-23 |
2024-05-02 |
인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰 메디칼르 |
그람 음성 박테리아 유출 펌프 억제제
|